NURIX THERAPEUTICS IN

Nurix Therapeutics to Participate in the 4th Annual Targeted Protein Degradation Summit

21 Oct 2021 07:00:01 By Nasdaq GlobeNewswire

Nurix Therapeutics Reports Third Quarter Fiscal 2021 Financial Results and Provides a Corporate Update

14 Oct 2021 16:02:00 By Nasdaq GlobeNewswire

Nurix Therapeutics Expands its Board of Directors with the Addition of Two Industry Leaders

30 Sep 2021 07:00:00 By Nasdaq GlobeNewswire

Nurix Therapeutics Reports Second Quarter Fiscal 2021 Financial Results and Provides a Corporate Update

13 Jul 2021 16:01:00 By Nasdaq GlobeNewswire

Nurix Therapeutics Announces Appointment of Stefani A. Wolff as Chief Operating Officer and Executive Vice President, Product Development

21 Jun 2021 16:01:00 By Nasdaq GlobeNewswire

Nurix Therapeutics Announces Presentation of Preclinical Data from NX-5948 Program Demonstrating Significant Reduction of Inflammation in a Model of Autoimmune Disease

02 Jun 2021 07:00:01 By Nasdaq GlobeNewswire

Nurix Therapeutics Appoints Industry Leader Clay Siegall, Ph.D., to its Board of Directors

01 Jun 2021 16:00:00 By Nasdaq GlobeNewswire

Nurix Therapeutics Announces Upcoming Presentation of NX-5948 Preclinical Data at the EULAR 2021 Virtual Congress

21 May 2021 07:00:00 By Nasdaq GlobeNewswire

Nurix Therapeutics to Participate in Upcoming Investor Conferences

11 May 2021 07:00:01 By Nasdaq GlobeNewswire

Nurix Therapeutics Reports First Quarter Fiscal 2021 Financial Results and Provides a Corporate Update

13 Apr 2021 16:01:02 By Nasdaq GlobeNewswire

Nurix Therapeutics Announces Participation in the 20th Annual Needham Virtual Healthcare Conference

07 Apr 2021 07:00:00 By Nasdaq GlobeNewswire

Nurix Therapeutics Announces Collaboration for the Discovery of Novel Drugs to Treat Pediatric Cancers

16 Mar 2021 09:31:21 By Nasdaq GlobeNewswire

Nurix Therapeutics Announces Presentation of NX-1607 Preclinical Data at AACR

10 Mar 2021 17:12:18 By Nasdaq GlobeNewswire

Nurix Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

09 Mar 2021 16:01:00 By Nasdaq GlobeNewswire

Nurix Therapeutics to Participate and Present at Upcoming Investor Conferences

09 Mar 2021 07:30:00 By Nasdaq GlobeNewswire

Nurix Therapeutics Announces Pricing of Upsized Public Offering of Common Stock

04 Mar 2021 20:01:29 By Nasdaq GlobeNewswire

Nurix Therapeutics Announces Launch of Proposed Public Offering of Common Stock

02 Mar 2021 16:15:45 By Nasdaq GlobeNewswire

Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2020 Financial Results and Provides a Corporate Update

16 Feb 2021 16:01:00 By Nasdaq GlobeNewswire

Nurix Therapeutics Announces Expansion of its Strategic Collaboration with Sanofi to Develop Novel Targeted Protein Degradation Therapies

07 Jan 2021 07:00:00 By Nasdaq GlobeNewswire